Teva and Sanuk are each have about a $75 million annual revenues. There is no way Sanuk and Teva combined will have $300 million in 2013 revenues. Maybe $200 million.
Anyway, Ugg brand revenue declines will lkely be double that of offsetting revenue gains rom Teva and Sanuk.
This is a key time for Deckrs management to recognize that the company should in the future deemphasize Uggs while building the Teva and Sanuk brands.
No, because Ugg brand is fashion oriented. Once a fashion concept falls out of consumer favor it does not return.
Deckers other brand, Teva, may have some sales gains, but not enough to overcome the declining Ugg brand revenues.